Denosumab is used in:
Correct Answer: Osteoporosis
Description: C i.e. OsteoporosisRef: GG,12th edition, page 1287Explanation:DenosumabRANKL binds to its cognate receptor RANK on the surface of precursor and mature osteoclasts, and stimulates these cells to mature and resorb bone.Osteoprotegerin (OPG), which competes with RANK for binding to RANKL, is the physiological inhibitor of RANKL.Denosumab is a human monoclonal antibody that binds with high affinity to RANKL, mimicking the effect of OPG, and thereby reducing the binding of RANKL to RANK.Denosumab blocks osteoclast formation and activation. It increases BMD and decreases bone turnover markers when given subcutaneously once every 6 months.Indications:Prevention of skeletal-related events in patients with bone metastases from solid tumors,Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now